Scientists are rapidly examining retatrutide, a innovative drug from Eli Lilly, as a possible breakthrough in weight reduction . Distinct from many previous approaches, retatrutide is a dual -action receptor targeting both GLP-1 and GIP, hormones that impact hunger and blood glucose balance. Pre